 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| CIIX Acquisition Will Provide Leadership and Growth in Digital Infrastructure and Go-to-Market Strategy |
|
 Hot Stock to Watch |
Company: ChineseInvestors.com (OTCQB: CIIX)
|
Last:
Price: 0.55
Change (%): - 0.17 (23.61)
Volume: 557,282 |
 |
ChineseInvestors.com, Inc. Announces That it has Retained Biopsy, LLC Managed by Bestselling Author Chris J. Snook to Provide Leadership in Growth and E-Commerce
SAN GABRIEL, California, September 11, 2017 /PRNewswire/ - ChineseInvestors.com, Inc. (OTCQB: CIIX) (‘CIIX’ or the ‘Company’) today announced that has retained Biopsy, LLC managed by Chris J Snook effective September 1, 2017 to provide leadership in growth and E-Commerce. Biopsy, LLC will be the architect of the digital infrastructure and go-to-market strategy for ChineseInvestors.com, Inc., its wholly owned subsidiary ChineseHempOil.com and its wholly owned foreign enterprise CBD Biotechnology Co., Ltd. reporting directly Warren Wang, CEO of ChineseInvestors.com, Inc., to Keevin Gillespie, President of ChineseHempOil.com, Inc. and to Summer Yun, CEO of CBD Biotechnology Co., Ltd.
Snook will work closely with the entire ChineseInvestors.com, Inc. team developing the strategy for and managing the execution of all internal and external communications related to IT, digital marketing, agency vendors, and the E-commerce, network marketing and retail divisions. Biopsy, LLC’s role will include informing and exciting consumers throughout Canada and the United States and Mainland China about ChineseInvestors.com, Inc.’s brands. Biopsy, LLC will oversee commerce initiatives, underlying data governance and digital architecture, go-to-market strategy, product and brand creation, and business development initiatives. As the managing member of Biopsy, LLC, Snook will also be directly involved with the Company’s media relations and executive and financial communications.
ChineseInvestors.com, Inc.’s decision to retain Biopsy, LLC comes at an important time as the Company has established several new relationships that will be managed by Biopsy, LLC including its selection of Elevated.com as its new digital agency of record in August and its recent agreement with Quiverr.com to drive sales of its hemp health products on the Amazon Channel. ChineseInvestors.com, Inc. plans to hire additional marketing talent that will assist to develop and manage its Chinese-American digital marketing strategy in the coming months. The Company’s objective is to add 1m dollars in new net revenues from these efforts in the coming 12 months.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
